Effectiveness of bupropion sustained release for smoking cessation in a health care setting - A randomized trial

被引:115
|
作者
Swan, GE
McAfee, T
Curry, SJ
Jack, LM
Javitz, H
Dacey, S
Bergman, K
机构
[1] SRI Int, Ctr Hlth Sci, Menlo Pk, CA 94025 USA
[2] Grp Hlth Cooperat Puget Sound, Ctr Hlth Promot, Seattle, WA 98121 USA
[3] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
[4] Grp Hlth Cooperat Puget Sound, Ctr Pharm Adm, Seattle, WA 98101 USA
关键词
D O I
10.1001/archinte.163.19.2337
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The efficacy of bupropion hydrochloride sustained release (SR) (Zyban) for smoking cessation has been evaluated in clinical trials that included frequent in-person behavioral counseling, but not in actual practice settings. Objective: To determine the differential effectiveness of 2 doses of bupropion SR in combination with behavioral interventions of minimal to moderate intensity in an actual practice setting. Design: Open-label randomized trial, with 1 year of follow-up. Setting: A large health system (Group Health Cooperative) based in Seattle. Participants: Adult smokers (N=1524) interested in quitting smoking. Interventions: Participants were randomly assigned to receive 1 of 4 combinations of bupropion SR (150 or 300 mg) and behavioral counseling (minimal or moderate intensity). Main Outcome Measures: The primary outcome measure was self-reported point-prevalence 7-day nonsmoking status at 3 and 12 months following the target quit date. Secondary outcomes included adverse and abstinence effects reported since beginning treatment with bupropion SR. Results: At 3 months, a significantly higher rate of nonsmoking was observed among those receiving the larger bupropion SR dose (P=.005). At 12 months, moderate intensity counseling was associated significantly with a higher rate of nonsmoking (P=.001). At 3 months, the higher dose was associated with a significantly increased frequency of self-reported symptoms such as difficulty sleeping (P=.02), difficulty concentrating (P=.02), shakiness/tremor (P=.002), and gastrointestinal problems (P=.005)and a decreased frequency of reported desire to smoke (P=.001). Conclusions: In this actual practice setting, the combination of bupropion SR and minimal or moderate counseling was associated with 1-year quit rates of 23.6% to 33.2%. This suggests that existing health care systems can substantially decrease tobacco use rates among their enrollees if they provide these modest interventions.
引用
收藏
页码:2337 / 2344
页数:8
相关论文
共 50 条
  • [21] Varenicline and bupropion sustained-release combination therapy for smoking cessation
    Ebbert, Jon O.
    Croghan, Ivana T.
    Sood, Amit
    Schroeder, Darrell R.
    Hays, J. Taylor
    Hurt, Richard D.
    [J]. NICOTINE & TOBACCO RESEARCH, 2009, 11 (03) : 234 - 239
  • [22] Tolerability and Safety of Sustained-Release Bupropion in the Management of Smoking Cessation
    Henri-Jean Aubin
    [J]. Drugs, 2002, 62 : 45 - 52
  • [23] Psychological mediators of bupropion sustained-release treatment for smoking cessation
    McCarthy, Danielle E.
    Piasecki, Thomas M.
    Lawrence, Daniel L.
    Jorenby, Douglas E.
    Shiffman, Saul
    Baker, Timothy B.
    [J]. ADDICTION, 2008, 103 (09) : 1521 - 1533
  • [24] Sustained-Release Bupropion for Smoking Cessation in a Chinese Sample: A Double-Blind, Placebo-Controlled, Randomized Trial
    Sheng, Li-xia
    Tang, Yi-lang
    Jiang, Zuo-ning
    Yao, Chong-hua
    Gao, Jun-yu
    Xu, Guo-Zhu
    Tong, Xin-yuan
    [J]. NICOTINE & TOBACCO RESEARCH, 2013, 15 (02) : 320 - 325
  • [25] RANDOMIZED, CONTROLLED TRIAL OF CLONIDINE FOR SMOKING CESSATION IN A PRIMARY CARE SETTING
    FRANKS, P
    HARP, J
    BELL, B
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (21): : 3011 - 3013
  • [26] Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release Bupropion for adolescent smoking cessation
    Muramoto, Myra L.
    Leischow, Scott J.
    Sherrill, Duane
    Matthews, Eva
    Strayer, Louise J.
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2007, 161 (11): : 1068 - 1074
  • [27] Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice
    Stapleton, John
    West, Robert
    Hajek, Peter
    Wheeler, Jenny
    Vangeli, Eleni
    Abdi, Zeinab
    O'Gara, Colin
    McRobbie, Hayden
    Humphrey, Kirsty
    Ali, Rachel
    Strang, John
    Sutherland, Gay
    [J]. ADDICTION, 2013, 108 (12) : 2193 - 2201
  • [28] Smoking cessation and the use of sustained-release bupropion as an aid to snioking cessation among Filipinos
    Silos, MH
    Fernandez, LC
    Covey, L
    [J]. CHEST, 2005, 128 (04) : 205S - 205S
  • [29] The effect of bupropion sustained-release on cigarette craving after smoking cessation
    Durcan, MJ
    Deener, G
    White, J
    Johnston, JA
    Gonzales, D
    Niaura, R
    Rigotti, N
    Sachs, DPL
    [J]. CLINICAL THERAPEUTICS, 2002, 24 (04) : 540 - 551
  • [30] Use of Sustained-Release Bupropion in Specific Patient Populations for Smoking Cessation
    Serena Tonstad
    [J]. Drugs, 2002, 62 : 37 - 43